{
    "ticker": "TNDM",
    "name": "Tandem Diabetes Care, Inc.",
    "description": "Tandem Diabetes Care, Inc. is a leading innovator in the field of diabetes management, dedicated to improving the lives of people with diabetes through advanced technology. Founded in 2006 and headquartered in San Diego, California, Tandem specializes in the development of insulin delivery systems that enhance the user experience and offer greater flexibility and freedom for patients. The company's flagship product, the t:slim X2 Insulin Pump, features a sleek design, touch-screen interface, and integrated technology that allows for continuous glucose monitoring and automated insulin delivery. Tandem's mission is to empower individuals living with diabetes by providing them with cutting-edge tools that simplify their daily management while ensuring optimal glycemic control. In addition to the t:slim X2, Tandem is actively involved in developing software solutions and applications that support diabetes management, including the t:connect mobile app, which offers real-time insights and data sharing capabilities. The company is committed to research and development, continuously seeking to enhance its product offerings and explore new technologies, including the potential for closed-loop systems. Tandem Diabetes Care is also focused on building partnerships with healthcare providers and diabetes organizations to further its reach and improve patient outcomes globally.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2006",
    "website": "https://www.tandemdiabetes.com",
    "ceo": "John Sheridan",
    "social_media": {
        "twitter": "https://twitter.com/tandemdiabetes",
        "linkedin": "https://www.linkedin.com/company/tandem-diabetes-care/"
    },
    "investor_relations": "https://investors.tandemdiabetes.com",
    "key_executives": [
        {
            "name": "John Sheridan",
            "position": "CEO"
        },
        {
            "name": "David J. M. J. G. R. L. L. W. D. R. B. W. S. W. K. R. R. B. G. S. R. F. F. S. S.",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Insulin Delivery Systems",
            "products": [
                "t:slim X2 Insulin Pump",
                "t:connect Mobile App"
            ]
        }
    ],
    "seo": {
        "meta_title": "Tandem Diabetes Care, Inc. | Innovative Diabetes Management Solutions",
        "meta_description": "Discover Tandem Diabetes Care, Inc., a leader in diabetes management technology. Explore Tandem's insulin delivery systems and commitment to improving patient lives.",
        "keywords": [
            "Tandem Diabetes",
            "Insulin Pumps",
            "Diabetes Management",
            "t:slim X2",
            "Continuous Glucose Monitoring"
        ]
    },
    "faq": [
        {
            "question": "What is Tandem Diabetes Care known for?",
            "answer": "Tandem Diabetes Care is known for its innovative insulin delivery systems, particularly the t:slim X2 Insulin Pump."
        },
        {
            "question": "Who is the CEO of Tandem Diabetes Care?",
            "answer": "John Sheridan is the CEO of Tandem Diabetes Care, Inc."
        },
        {
            "question": "Where is Tandem Diabetes Care headquartered?",
            "answer": "Tandem Diabetes Care is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are Tandem's main products?",
            "answer": "Tandem's main products include the t:slim X2 Insulin Pump and the t:connect Mobile App."
        },
        {
            "question": "When was Tandem Diabetes Care founded?",
            "answer": "Tandem Diabetes Care was founded in 2006."
        }
    ],
    "competitors": [
        "DXCM",
        "OMCL",
        "MANN"
    ],
    "related_stocks": [
        "AAPL",
        "GOOGL",
        "AMZN",
        "MSFT"
    ]
}